Abridge Expands AI Clinical Decision Support to All Clinicians

Abridge scales clinical decision support across enterprise health systems

Abridge is making its AI-powered clinical decision support solution available to every clinician at its partner health systems, marking a significant expansion beyond the company's core ambient documentation offering. Since launching the decision support tool in April, more than 300 enterprise health systems have adopted it, serving over 250 million patients collectively.

The company reports that monthly active users have reached more than half of eligible Abridge clinicians, with queries per clinician tripling in the past two months. CEO and co-founder Shiv Rao, a practicing cardiologist, attributed the rapid uptake to the tool's natural integration with existing workflows and its grounding in trusted clinical evidence.

Why it matters

As healthcare organizations grapple with clinician burnout and the challenge of keeping pace with expanding medical knowledge, enterprise-grade AI decision support represents a potential shift from reactive information retrieval to proactive clinical guidance. The expansion also signals how ambient AI companies are evolving from single-purpose documentation tools into comprehensive clinical intelligence platforms—a move that could reshape how health systems approach AI procurement and governance.

Integration with trusted medical sources

Abridge developed its clinical decision support capabilities through a partnership with Wolters Kluwer's UpToDate, a clinical evidence solution with three decades of market presence. The system also integrates content from The New England Journal of Medicine, the JAMA Network, the American Diabetes Association, and other authoritative medical literature.

For clinicians already using Abridge as an AI scribe, the decision support agent operates within their existing workflow. For other clinicians at participating organizations, it arrives as a standalone AI assistant experience on mobile and desktop platforms. Health systems can deploy the solution through the same enterprise-approved infrastructure used for Abridge's documentation tools, including existing security protocols and electronic health record integrations.

Real-world clinical applications

Dr. Eric Poon, Chief Health Information Officer at Duke Health and an adult primary care physician, described using the system during an appointment with a patient presenting a rare neurological condition. The decision support tool surfaced relevant clinical guidance without requiring him to interrupt the patient conversation or search external resources.

"It's like having an English butler at my side, anticipating my needs," Poon said. He noted that while he doesn't use the feature in every encounter, its availability when needed feels "magical." Approximately 2,000 clinicians at Duke Health currently use Abridge.

Health systems deploying the solution include Kaiser Permanente, Sutter Health, UNC Health, CHRISTUS Health, Duke Health, and UPMC. At UPMC, more than 60% of Abridge users adopted the clinical decision support feature through self-discovery, with no additional training required, according to Dr. Robert Bart, the system's chief medical information officer.

Addressing shadow AI concerns

Abridge positions the enterprise-wide rollout as a secure alternative to "shadow AI"—unauthorized AI tools clinicians might use outside approved workflows. Matt Troup, a certified physician assistant and Abridge's head of clinical strategy, emphasized that the company has "earned the right" to expand into decision support by first building trust through documentation tools.

The company's technology currently supports more than 100 million clinical conversations annually across its health system partners. Beyond decision support, Abridge has expanded its platform to include pre-visit summaries, structured documentation generation, and integrations with payer and life sciences workflows.

Balancing automation and clinical judgment

The expansion raises ongoing questions about preserving clinician autonomy as AI becomes more deeply embedded in care delivery. Poon acknowledged that AI is "rapidly democratizing expertise" while emphasizing that judgment and critical thinking remain in the clinician's domain.

Troup stated that Abridge aims to build the intelligence infrastructure while preserving the clinician's role as the ultimate decision-maker and validation step in patient care.

These details were first reported by Fierce Healthcare.